Organization
Novo Nordisk A/S
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Novo Nordisk A/S
... Pharmaceutical Co.'s $627-million deal for TiGenix. Volume may soon grow further as Novo Nordisk pursues Ablynx. Novo went public with its $3.2-billion offer for the ...
... and booking of explored reserves are in progress ZABAIKALSKY REGION, RUSSIA Novoshirokinskoye (Novo) Ore mining in Q4 2017 totalled 222,488 tonnes, a 13% increase over ...
... Ablynx’s largest shareholder is open to supporting a takeover by Novo Nordisk. The fund, Van Herk Investments, thinks Novo’s most recent offer was ...
... Pharma's layoffs in 2016: report Along with diabetes drugmakers Eli Lilly and Novo Nordisk, the French pharma giant has been suffering from U.S. payer pressure ...
... total capital invested. In the large cap segment, profits were taken in Novo Nordisk following its strong recovery and the cash was reinvested in Celgene ...
... CGM," Kowalski said. The study was published in The Lancet. Insulin speed Novo Nordisk received FDA approval for a new insulin called Fiasp. This insulin ...
... Bagsvaerd, Denmark - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of ...
... The resignation of Peter Fellner raised doubts about Ablynx’s united front against Novo Nordisk’s takeover bid. Fellner quit as chairman with immediate effect on the ...
... a while before coming to a conclusion. The ongoing, uncertain story involves Novo Nordisk. Facing pressures on its diabetes business, the Danish drugmaker approached Ablynx ...
... d'intelligence artificielle FLAIRE, annonce aujourd'hui la mise en oeuvre d'une collaboration avec Novo Nordisk pour assurer le suivi de patients souffrant du diabete. Source: TMX ...
... FLAIRE platform based on Artificial Intelligence (AI), announces today an alliance with Novo Nordisk to monitor diabetes patients. "At Novo Nordisk, we strive to empower ...
... Bagsvaerd, Denmark - Novo Nordisk today confirms that it made a proposal on 22 December 2017 ...
... in an area that is already catered for. We also know that Novo Nordisk is on the hunt for Ablynx with a multibillion-dollar offer, but ...
... Novo Nordisk A/S has traditionally eschewed deals and looked inward to develop new treatments. ...
... HELSINKI (AP) - Danish drugmaker Novo Nordisk has revised up its offer for Belgian biotech company Ablynx as ...
... grass allergies. 5. Belgian biotech Ablynx rejected a $3.1 billion bid by Novo Nordisk, saying that it "undervalues Ablynx and its strong prospects." Ablynx's experimental ...
... Novo Nordisk has gone public with its €2.6 billion ($3.1 billion) bid to ...
... the forecast period. To enhance the overall sustainability, established players such as Novo Nordisk, Sanofi, and Eli Lilly are continuously investing in the development of ...
... biotechnology companies. The Adimab technology has been transferred and implemented at Merck, Novo Nordisk, Biogen, GSK and Lilly. Funded discovery partners include leading pharmaceutical companies, ...
... December 22, 2017 it received an unsolicited conditional proposal from Novo Nordisk A/S (CSE: NOVO B) (NYSE:NVO) ("Novo Nordisk") to acquire all of the outstanding ...
... its kind to win a green light in the United States, while Novo Nordisk’s novo-nordisk-as Ozempic was the sixth of its type. Both were approved ...
... blood sugar levels and also helps people lose significant weight. Danish drugmaker Novo Nordisk said the Food and Drug Administration approved its once-a-week shot for ...
... -Novo Nordisk A S - Share repurchase programme ...
... Bagsvaerd, Denmark - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use ...
Want to see the full history on Novo Nordisk A/S? Upgrade to RelSci Pro now!
Start My Free Trial